Lipoprotein physiology

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 3, 1998, Pages 503-519

  Ginsberg, H N ^a  

^a Columbia Univ Coll of Phys/Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL ESTERIFICATION; DISEASE PREDISPOSITION; DYSLIPOPROTEINEMIA; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0031686285     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70023-2     Document Type: Article

References (40)

1. K. Aalto-Setala E.A. Fisher X. Chen Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic Mice J Clin Invest 90 1992 1889 1900
2. Y. Arad R. Ramakrishnan H.N. Ginsberg Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: Implications for the pathophysiology of apoB production J Lipid Res 31 1990 567 582
3. M.A. Austin J.E. Hokanson Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein (a) as risk factors for coronary heart disease Med Clin North Am 78 1994 99 115
4. P.J. Barter K.A. Rye High-density lipoproteins and coronary heart disease J Cardiovasc Risk 1 1994 217 221
5. A. Bensadoun D.E. Berryman Genetics and molecular biology of hepatic lipase Curr Opin Lipidol 7 1996 77 81
6. E. Boerwinkle H.J. Menzel H.G. Kraft Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation Hum Genet 82 1989 73 78
7. W.C. Breckenridge J.A. Little G. Steiner Hypertriglyceridemia associated with deficiency of apolipoprotein C-II N Engl J Med 298 1978 1265 1273
8. M.S. Brown J.L. Goldstein How LDL receptors influence cholesterol and atherosclerosis Sci Am 251 1984 58 66
9. M.S. Brown J.L. Goldstein The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
10. C. Bruce A.R. Tall Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis Curr Opin Lipidol 6 1995 306 311
11. J.L. Dixon H.N. Ginsberg Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells J Lipid Res 34 1993 167 179
12. S. Eisenberg High density lipoprotein metabolism J Lipid Res 25 1984 1017 1058
13. E. Fisher M. Zhou D.M. Mitchell Apoprotein B100, an atypical secretory protein, can be degraded by a cytosolic pathway involving heat shock protein 70 and proteasomes J Biol Chem 272 1997 20427 20434
14. H.N. Ginsberg N. Le I.J. Goldberg Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C-III and A-I: Evidence that apolipoprotein C-III inhibits lipoprotein lipase in vivo J Clin Invest 78 1986 1287 1295
15. J.A. Glosmet The plasma lecithin: Cholesterol acyltransferase reaction J Lipid Res 9 1968 155 167
16. I.J. Goldberg Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherosclerosis J Lipid Res 37 1996 693 707
17. Gotto A.M. Jr H.J. Pownall R.J. Havel Introduction to the plasma lipoproteins Methods Enzymol 128 1986 3 41
18. M.R. Hayden M.S. Liu Y. Ma Gene environment interaction and plasma triglyceride levels: The crucial role of lipoprotein lipase Clin Genet 46 1994 15 18
19. J. Herz T.E. Willnow Lipoprotein and receptor interactions in vivo Curr Opin Lipidol 6 1995 97 103
20. J.M. Hoeg B.L. Vaisman Demosky S.J. Jr Lecithin: Cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits J Biol Chem 271 1996 4396 4402
21. B.S. Horowitz I.J. Goldberg J. Merab Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol J Clin Invest 91 1993 1743 1752
22. B.V. Howard Lipoprotein metabolism in diabetes mellitus J Lipid Res 28 1987 613 628
23. A.H. Kissebah A. Alfarsi P.W. Adams Integrated regulation for very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia Metabolism 20 1981 856 868
24. G.M. Kostner G. Knipping J.E. Groener The role of LCAT and cholesteryl ester transfer proteins for the HDL and LDL structure and metabolism Adv Exp Med Biol 210 1987 79 86
25. K.T. Landschulz R.K. Pathak A. Rigotti Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat J Clin Invest 98 1996 984 995
26. A. Leroy J. Dallongeville J.C. Fruchart Apolipoprotein A-I-containing lipoproteins and atherosclerosis Curr Opin Lipidol 6 1995 281 285
27. G.F. Lewis Fatty acid regulation of very low density lipoprotein (VLDL) production Curr Opin Lipidol 9 1998 171 173
28. R.W. Mahley Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
29. R.W. Mahley S.C. Rall Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism Servier C.R. Bendit A.L. Sly W.S. Valle D. The Metabolic Basis of Inherited Disorders Vol. 6 1989 McGraw-Hill New York 1195 1214
30. C.J. Packard A. Munro A.R. Lorimer Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects J Clin Invest 74 1984 2178 2192
31. A.S. Plump J.D. Smith T. Hayek Severe hypercholesterolemia and atherosclerosis in apolipoprotein E–deficient mice created by homologous recombination in ES cells Cell 71 1992 343 353
32. G.M. Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
33. N.S. Shachter T. Ebara R. Ramakrishnan Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI J Clin Invest 98 1996 846 855
34. N.S. Shachter T. Leff J.D. Smith Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice J Clin Invest 93 1994 1683 1690
35. A.R. Tall Plasma high density lipoproteins: Metabolism and relationship to atherogenesis J Clin Invest 86 1990 379 384
36. P.J. Talmud S.E. Humphries Apolipoprotein CIII gene variation and dyslipidaemia Curr Opin Lipidol 8 1997 154 158
37. B. Teng A.D. Sniderman A.K. Soular Metabolic basis of hyperapobetalipoproteinemia: Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia J Clin Invest 77 1986 663 672
38. P.H. Weinstock C.L. Bisgaier K. Aalto-Setala Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes J Clin Invest 96 1995 2555 2568
39. J.R. Wetterau L.P. Aggerbeck M.E. Bouma Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia Science 258 1992 999 1001
40. H. Yki-Jarvinen M. Taskinen Interrelationship among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia Diabetes 37 1988 1271 1278